Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
· cnbc.com · popularity 38/100 · 0 similar stories today
Read the original at cnbc.com →
Summary
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Found in: CNBC Top News. Rating basis: single outlet; outlet tier 5; 1 feeds; feed position 6.